Literature DB >> 3020031

Intracellular modifications of human apolipoprotein E.

V I Zannis, J vanderSpek, D Silverman.   

Abstract

We have used pulse-chase techniques to study the synthesis, intracellular modification, and secretion of human apolipoprotein E by cultures of HepG2 cells and peripheral blood human monocyte macrophages. We have found that modified apoE isoproteins are detectable intracellularly after 14 min of pulse, and their relative concentration increases linearly over a 2-h pulse-chase period. At the same time, the relative concentration of unmodified apoE decreases. All the major modified apoE isoproteins appear simultaneously, and they correspond to the sialo apoE forms apooEs2, apoEs4, and apoEs6. ApoE secretion is first detected after a 30-min pulse. Secreted apoE consists of 92% of the same sialated apoE forms observed intracellularly. ApoE sialation and secretion were not affected by treatment of the HepG2 cultures with tunicamycin, whereas monensin inhibited both the intracellular sialation and secretion of this protein. These findings suggest that apoE is secreted in the form of three major isoproteins generated by intracellular modification of this protein with one or more O-linked oligosaccharide chains containing sialic acid.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3020031

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  O-glycosylation on cerebrospinal fluid and plasma apolipoprotein E differs in the lipid-binding domain.

Authors:  Sarah A Flowers; Oliver C Grant; Robert J Woods; G William Rebeck
Journal:  Glycobiology       Date:  2020-01-28       Impact factor: 4.313

Review 2.  The role of apolipoprotein E in Guillain-Barré syndrome and experimental autoimmune neuritis.

Authors:  Hong-liang Zhang; Jiang Wu; Jie Zhu
Journal:  J Biomed Biotechnol       Date:  2010-02-16

3.  Identification and modification of amyloid-independent phenotypes of APOE4 mice.

Authors:  Amanda M DiBattista; Sonya B Dumanis; Joshua Newman; G William Rebeck
Journal:  Exp Neurol       Date:  2016-04-14       Impact factor: 5.330

4.  Gene delivery of human apolipoprotein E alters brain Abeta burden in a mouse model of Alzheimer's disease.

Authors:  Jean-Cosme Dodart; Robert A Marr; Milla Koistinaho; Beth M Gregersen; Seema Malkani; Inder M Verma; Steven M Paul
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-18       Impact factor: 11.205

Review 5.  APOE in the normal brain.

Authors:  Sarah A Flowers; G William Rebeck
Journal:  Neurobiol Dis       Date:  2020-01-03       Impact factor: 5.996

6.  Glycosylation and sialylation of macrophage-derived human apolipoprotein E analyzed by SDS-PAGE and mass spectrometry: evidence for a novel site of glycosylation on Ser290.

Authors:  Youra Lee; Maaike Kockx; Mark J Raftery; Wendy Jessup; Renate Griffith; Leonard Kritharides
Journal:  Mol Cell Proteomics       Date:  2010-05-28       Impact factor: 5.911

7.  Interferon-gamma inhibits macrophage apolipoprotein E production by posttranslational mechanisms.

Authors:  K Brand; N Mackman; L K Curtiss
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

8.  Cyclosporin A decreases apolipoprotein E secretion from human macrophages via a protein phosphatase 2B-dependent and ATP-binding cassette transporter A1 (ABCA1)-independent pathway.

Authors:  Maaike Kockx; Dongni Lily Guo; Mathew Traini; Katharina Gaus; Jason Kay; Sabine Wimmer-Kleikamp; Carles Rentero; John R Burnett; Wilfried Le Goff; Miranda Van Eck; Jennifer L Stow; Wendy Jessup; Leonard Kritharides
Journal:  J Biol Chem       Date:  2009-07-09       Impact factor: 5.157

9.  Macrophages from nephrotic rats regulate apolipoprotein E biosynthesis and cholesterol content independently.

Authors:  J Bass; E A Fisher; M M Prack; D L Williams; J B Marsh
Journal:  J Clin Invest       Date:  1991-02       Impact factor: 14.808

10.  Expression and secretion of apoE isoforms in astrocytes and microglia during inflammation.

Authors:  Maria Fe Lanfranco; Jordy Sepulveda; Gregory Kopetsky; G William Rebeck
Journal:  Glia       Date:  2021-02-08       Impact factor: 8.073

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.